RECRUITING

Virtual Reality Visual Field Testing as an Alternative in Childhood Eye Disease

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this study is to test a new way of measuring the peripheral vision (called a visual field test) using a device which can be worn as goggles rather than being a large instrument the patient must sit at. This new visual field test (called VisuALL) is an FDA-approved virtual reality system which has been used in adults and children. This study will compare the performance of the VisuALL to the standard testing for peripheral vision, which is called the Humphrey Visual Field (HVF) test. The study will recruit both healthy children, as well children and young adults who have eye conditions which require visual field testing as part of their standard care. The test will be performed on a day when the child or young adult already has a scheduled eye appointment as standard care. The test does not touch the eyes or require any eye drops to be given, and there is no known risk associated with the test itself. There may be a risk of loss of confidentiality. Participating in this study will require approximately 30 minutes, has no extra cost associated with it, and will be compensated by a parking pass for the day of the visit. There are no direct benefits for participants. Selected participants will be also be given training and then loaned a home VisuALL system to allow home visual field testing. If your child is selected, additional information would be provided.

Official Title

Virtual Reality Visual Field Testing as an Alternative to Standard Automated Perimetry in Childhood Eye Disease

Quick Facts

Study Start:2022-01-19
Study Completion:2025-02-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05150197

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:4 Years to 21 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:CHILD, ADULT
Inclusion CriteriaExclusion Criteria
  1. * Patients must be 17 years or younger, OR patients from 18-21 years of age must have been diagnosed with their condition prior to their 18th birthday
  2. * Cognitively normal (no developmental delay or syndrome)
  3. * Be able to tolerate wearing the virtual reality goggles for at least 10 minutes
  4. * Be able to provide informed consent of a parent/guardian (and assent if 12 years or older)
  5. * Do not have any ocular diseases that could interfere with the visual field testing
  1. * Developmental delay
  2. * Inability to obtain consent
  3. * Inability to understand English

Contacts and Locations

Study Contact

Samuel A Alvarez, MD
CONTACT
919-684-0560
samuel.alvarez544@duke.edu

Principal Investigator

Sharon F Freedman, MD
PRINCIPAL_INVESTIGATOR
Duke University

Study Locations (Sites)

Duke University Medical Center
Durham, North Carolina, 27705
United States

Collaborators and Investigators

Sponsor: Duke University

  • Sharon F Freedman, MD, PRINCIPAL_INVESTIGATOR, Duke University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2022-01-19
Study Completion Date2025-02-01

Study Record Updates

Study Start Date2022-01-19
Study Completion Date2025-02-01

Terms related to this study

Keywords Provided by Researchers

  • Virtual Reality Visual Field
  • Glaucoma
  • Neuro-ophthalmology

Additional Relevant MeSH Terms

  • Visual Field Defect, Peripheral